Discover
MDCX
Medicus Pharma Ltd.
0.09
1 x 0.16
5 x 0.16
bid
ask
-
0.01
9.62%
3 @ 07:46 PM
0.09 -0.01 (6.95%)
| Ytd | -98.19% | |
| 1y | -98.19% |
0.08
day range
0.09
0.09
52 week range
5.09
| Open | 0.09 | Prev Close | 0.10 | Low | 0.08 | High | 0.09 | Mkt Cap | 138.07K |
| Vol | 17.33M | Avg Vol | 92.96K | EPS | -119.00 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.30 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 11.00 | 200-d Avg | 27.13 | 1yr Est | 7.80 |
| Income Statement | |||
| Operating Expenses | 11.48M | ||
| Research and Development Expense | 4.91M | ||
| Selling, General and Administrative Expense | 6.57M | ||
| Operating Income | -11.48M | ||
| Interest Expense | 205.64K | ||
| Net Income | -11.68M | ||
| Net Income Common Stock | -11.62M | ||
| Net Income Common Stock (USD) | -11.62M | ||
| Consolidated Income | -11.68M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -11.48M | ||
| Earning Before Interest & Taxes (USD) | -11.48M | ||
| Preferred Dividends Income Statement Impact | -66.72K | ||
| Weighted Average Shares | 55.06M | ||
| Weighted Average Shares Diluted | 55.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 25.19M | ||
| Cash and Equivalents (USD) | 25.19M | ||
| Current Assets | 16.98M | ||
| Property, Plant & Equipment Net | 117.18K | ||
| Total Assets | 27.12M | ||
| Debt Current | 3.64M | ||
| Total Debt | 21.64M | ||
| Current Liabilities | 10.84M | ||
| Debt Non-Current | 18.00M | ||
| Total Liabilities | 28.84M | ||
| Accumulated Retained Earnings (Deficit) | -85.01M | ||
| Accumulated Other Comprehensive Income | 61.10K | ||
| Shareholders Equity | -1.76M | ||
| Shareholders Equity (USD) | -1.76M | ||
| Assets Non-Current | 10.13M | ||
| Total Debt (USD) | 21.64M | ||
| Liabilities Non-Current | 18.00M | ||
| Trade and Non-Trade Payables | 6.90M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 25.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 18.83M | ||
| Issuance (Purchase) of Equity Shares | 6.49M | ||
| Issuance (Repayment) of Debt Securities | 19.04M | ||
| Net Cash Flow from Operations | -6.98M | ||
| Effect of Exchange Rate Changes on Cash | 279.57K | ||
| Share Based Compensation | 1.78M | ||